Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors

Journal of Physiology and Pharmacology

Volumn 60, Issue SUPPL. 1, 2009, Pages 73-84

  Rao, N A S ^a   Van Wolferen, M E ^a   Gracanin, A ^a   Bhatti, S F M ^b   Krol, M ^c   Holstege, F C ^d   Mol, Jan A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

^c WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Canine mammary carcinoma; Canine mammary hyperplasia; Gene expression profile; Progesterone

Indexed keywords

A KINASE ANCHOR PROTEIN 8; ADENOSINE A1 RECEPTOR; ASPARTATE AMMONIA LIGASE; CARBONYL REDUCTASE; CARBONYL REDUCTASE 3; CD31 ANTIGEN; CELL ADHESION MOLECULE; CHAPERONIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLINE; DECORIN; DIPEPTIDYL PEPTIDASE; DIPEPTIDYL PEPTIDASE 10; DIPEPTIDYL PEPTIDASE I; FIBRILLIN 1; GELSOLIN; GESTAGEN; JUNCTIONAL ADHESION MOLECULE 2; KARYOPHERIN ALPHA; KARYOPHERIN ALPHA 1; KRUPPEL LIKE FACTOR 4; NEUROPEPTIDE Y; NUCLEOPHOSMIN; REELIN; STATHMIN; STATHMIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR; TRANSKETOLASE; UNCLASSIFIED DRUG; VIMENTIN;

AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BREAST HYPERPLASIA; BREAST TUMOR; CELL ADHESION; CELL MOTILITY; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA MICROARRAY; EXPERIMENTAL DOG; EXTRACELLULAR MATRIX; FATTY ACID METABOLISM; GENE EXPRESSION; GENE EXPRESSION PROFILING; NONHUMAN; PROTEIN DEGRADATION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; CELL PROLIFERATION; DOGS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HYPERPLASIA; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGESTERONE; PROGESTINS; TUMOR MARKERS, BIOLOGICAL;

EID: 67749143727     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2005; 55: 74-108.
2. Benjamin SA, Lee AC, Saunders WJ. Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles. Vet Pathol 1999; 36: 423-436.
3. MacEwen EG. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 1990; 9: 125-136.
4. Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 1998; 3: 49-61. (Pubitemid 128513219)
5. Schneider R, Dorn CR, Taylor DO. Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst 1969; 43: 1249-1261.
6. Bhatti SF, Rao NA, Okkens AC et al. Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch. Domest Anim Endocrinol 2007; 33: 294-312.
7. Chlebowski RT, Hendrix SL, Langer RD et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003; 289: 3243-3253. (Pubitemid 37430077)
8. Selman PJ, Mol JA, Rutteman GR, Garderen van E, Rijnberk A. Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 1994; 134: 287-292. (Pubitemid 24022000)
9. Evans JM, Uvarov O, Valliance DK. Hormonal control of the oestrus cycle in the bitch. Vet Rec 1969; 85: 233-234.
10. Kwapien RP, Giles RC, Geil RG, Casey HW. Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids. J Natl Cancer Inst 1980; 65: 137-144.
11. Brisken C, Heineman A, Chavarria T et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 2000; 14: 650-654. (Pubitemid 30176819)
12. Millanta F, Calandrella M, Bari G, Niccolini M, Vannozzi I, Poli A. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Res Vet Sci 2005; 79: 225-232. (Pubitemid 41070360)
13. Las Mulas de JM, Millan Y, Dios R. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Vet Pathol 2005; 42: 200-212. (Pubitemid 40797309)
14. Hacene K, Desplaces A, Brunet M, Lidereau R, Bourguignat A, Oglobine J. Competitive prognostic value of clinicopathologic and bioimmunologic factors in primary breast cancer. Cancer 1986; 57: 245-250. (Pubitemid 16212026)
15. Kurzman ID, Gilbertson SR. Prognostic factors in canine mammary tumors. Semin Vet Med Surg (Small Anim) 1986; 1: 25-32.
16. Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752.
17. Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869-10874. (Pubitemid 32878711)
18. Sorlie T, Tibshirani R, Parker J et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003; 100: 8418-8423. (Pubitemid 36842560)
19. Fan C, Oh DS, Wessels L et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006; 355: 560-569. (Pubitemid 44200649)
20. Rao NAS, Ham van de R, Leenen van D et al. cDNA microarray profiles of canine mammary tumor cell lines reveal deregulated pathways pertaining to their phenotype. Animal Genetics 2008; 39: 333-345.
21. Yang YH, Dudoit S, Luu P et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30: e15.
22. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121. (Pubitemid 32397092)
23. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005; 33: D284-D288. (Pubitemid 40207879)
24. Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 1999; 84: 4559-4565.
25. Korner M, Reubi JC. NPY receptors in human cancer: a review of current knowledge. Peptides 2007; 28: 419-425. (Pubitemid 46176252)
26. Kalra SP. Mandatory neuropeptide-steroid signaling for the preovulatory luteinizing hormone-releasing hormone discharge. Endocr Rev 1993; 14: 507-538.
27. Kasuya E, Mizuno M, Watanabe G, Terasawa E. Effects of an antisense oligodeoxynucleotide for neuropeptide Y mRNA on in vivo luteinizing hormone-releasing hormone release in ovariectomized female rhesus monkeys. Regul Pept 1998; 75-76: 319-325. (Pubitemid 28477543)
28. Woller MJ, Terasawa E. Changes in pulsatile release of neuropeptide-Y and luteinizing hormone (LH)-releasing hormone during the progesterone-induced LH surge in rhesus monkeys. Endocrinology 1994; 135: 1679-1686. (Pubitemid 24307549)
29. Yonaha H, Minoura H, Yoshida T et al. Expression of neuropeptide Yis increased in murine endometrial epithelium during the peri-implantation period under regulation by sex steroids. Reprod Fertil Dev 2004; 16: 355-361. (Pubitemid 39004394)
30. Ouellet V, Guyot MC, Le Page C et al. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int J Cancer 2006; 119: 599-607. (Pubitemid 43955714)
31. Tyagi RK, Amazit L, Lescop P, Milgrom E, Guiochon-Mantel A. Mechanisms of progesterone receptor export from nuclei: role of nuclear localization signal, nuclear export signal, and ran guanosine triphosphate. Mol Endocrinol 1998; 12: 1684-1695. (Pubitemid 28492445)
32. Zhang W, Chen X, Kato Y et al. Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol Cell Biol 2006; 26: 2055-2064. (Pubitemid 43346910)
33. Bover L, Barrio M, Bravo AI et al. The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo. Cell Mol Biol (Noisy-le-grand) 1998; 44: 493-504.
34. Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 1994; 31: 325-335. (Pubitemid 24323473)
35. Cheung TH, Leung JO, Chung TK, Lam SK, To KF, Wong YF. c-fos overexpression is associated with the pathoneogenesis of invasive cervical cancer. Gynecol Obstet Invest 1997; 43: 200-203. (Pubitemid 27166002)
36. Girault I, Lerebours F, Amarir S et al. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. Clin Cancer Res 2003; 9: 1259-1266. (Pubitemid 36418375)
37. Shao W, Halachmi S, Brown M. ERAP140, a conserved tissue-specific nuclear receptor coactivator. Mol Cell Biol 2002; 22: 3358-3372. (Pubitemid 34453977)
38. Gluck U, Ben-Ze'ev A. Modulation of alpha-actinin levels affects cell motility and confers tumorigenicity on 3T3 cells. J Cell Sci 1994; 107: 1773-1782. (Pubitemid 2108474)
39. Muschler J, Levy D, Boudreau R, Henry M, Campbell K, Bissell MJ. A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res 2002; 62: 7102-7109. (Pubitemid 35424106)
40. Nakamura Y, Nishisho I, Kinzler KW et al. Mutations of the adenomatous polyposis coli gene in familial polyposis coli patients and sporadic colorectal tumors. Princess Takamatsu Symp 1991; 22: 285-292.
41. McClung HM, Thomas SL, Osenkowski P et al. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells. Neurosci Lett 2007; 419: 172-177. (Pubitemid 46719671)
42. Tang L, Dai DL, Su M, Martinka M, Li G, Zhou Y. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res 2006; 12: 3716-3722. (Pubitemid 44000252)
43. Kleiber K, Strebhardt K, Martin BT. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target. Anticancer Res 2007; 27: 55-61. (Pubitemid 46363316)
44. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469-480.
45. Wang Y, Kakinuma N, Zhu Y, Kiyama R. Nucleocytoplasmic shuttling of human Kank protein accompanies intracellular translocation of beta-catenin. J Cell Sci 2006; 119: 4002-4010. (Pubitemid 44650873)
46. Hartmann LC, Sellers TA, Frost MH et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005; 353: 229-237. (Pubitemid 41058322)